Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

AXA Framlington Health Fund

+ Add to Watchlist

AXAHLZA:LN

216.90 GBp 0.50 0.23%

As of 00:59:30 ET on 05/29/2015.

Snapshot for AXA Framlington Health Fund (AXAHLZA)

Year To Date: +15.19% 3-Month: +6.32% 3-Year: +28.81% 52-Week Range: 150.88 - 223.20
1-Month: +4.43% 1-Year: +42.34% 5-Year: - Beta vs FTWBWRLD: 0.98

Mutual Fund Chart for AXAHLZA

No chart data available.
  • AXAHLZA:LN 216.90
  • 1M
  • 1Y
Interactive AXAHLZA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for AXAHLZA

AXA Framlington Health Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to achieve capital growth. It invests in producers of pharmaceuticals, bio-technology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies along ethical guidelines.

Inception Date: 04-16-2012 Telephone: 44-207-374-4100
Managers: MARK HARGRAVES / LINDEN THOMSON
Web Site: www.axa-framlington.com

Fundamentals for AXAHLZA

NAV (on 2015-05-29) 216.90
Assets (M) (on 2015-01-30) 511.60
Fund Leveraged N
Minimum Investment 100,000.00
Minimum Subsequent Investment 5,000.00

Dividends for AXAHLZA

Dividend Type Accumulation
Dividend Frequency Semi-Anl
Last Dividend Net -
Dividend Yield (ttm) 0.12

Fees & Expenses for AXAHLZA

Front Load 0.00
Back Load -
Current Mgmt Fee 0.75
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for AXAHLZA

Filing Date: 04/30/2015
Name Position Value % of Total
Roche Holding AG 160,469 30,049,600 5.600%
Gilead Sciences Inc 392,951 25,756,800 4.800%
Novartis AG 351,441 23,610,400 4.400%
Amgen Inc 209,456 21,464,000 4.000%
AbbVie Inc 470,839 19,854,200 3.700%
Biogen Inc 70,415 17,171,200 3.200%
Actavis plc 81,450 15,024,800 2.800%
Medtronic PLC 287,352 13,951,600 2.600%
UnitedHealth Group Inc 184,655 13,415,000 2.500%
Celgene Corp 182,748 12,878,400 2.400%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil